Telemedicine Enhanced Asthma Management Through the Emergency Department



Status:Recruiting
Conditions:Asthma, Hospital
Therapuetic Areas:Pulmonary / Respiratory Diseases, Other
Healthy:No
Age Range:4 - 12
Updated:4/6/2019
Start Date:August 2016
End Date:April 2022
Contact:Maria Fagnano, MPH
Email:maria_fagnano@urmc.rochester.edu
Phone:585-275-8220

Use our guide to learn which trials are right for you!

In the US, children from minority ethnic and racial backgrounds suffer disproportionately
from asthma and account for substantially more emergency department (ED) visits and
hospitalizations than non-minority children. While NHLBI guidelines recommend daily
preventive medications for all children with persistent asthma to prevent morbidity as well
as ED visits and hospitalizations, many children who should receive preventive medications
are not receiving them. This is in part because children presenting to the ED for an acute
asthma exacerbation rarely receive preventive asthma care, due to the ED's focus on acute,
episodic care. The NHLBI guidelines recommend that children follow-up with a primary care
provider (PCP) within 1-4 weeks of the ED visit. The post-ED follow-up visit is an
opportunity for the PCP to prescribe effective preventive asthma medications, step-up
medication for children who demonstrate poor control, promote adherence, and provide
education on asthma self-management and trigger control. However, rates for follow-up after
an asthma-related ED visit are extremely low, and preventive care is delivered inconsistently
even when children are seen in follow-up. In the investigators' prior work they have found
that a provider prompting intervention can enhance the delivery of guideline-based preventive
asthma treatments at the time of a primary care office visit and ultimately reduce morbidity.
They have also found that telemedicine can link children with persistent asthma to a provider
for optimal chronic illness management. The goal of this project is to use a novel
telemedicine-based program to facilitate primary care follow-up and promote the delivery of
guideline-based preventive care for high-risk children presenting to the ED for an asthma
exacerbation. The investigators will utilize a 2-group randomized trial to test the TEAM-ED
intervention. The intervention includes: 1) a telemedicine assessment at the child's school
within one week of discharge from the ED and completed by a PCP, 2) 'point-of-care' prompting
to promote the provision of guideline-based preventive care during the telemedicine visit,
and 3) two additional telemedicine-assisted follow-up assessments to assure optimal response
to treatment and tailor the care regimen as needed. The investigators will assess the
effectiveness of the program in reducing respiratory morbidity and improving preventive
asthma care, with follow-up assessments at 3, 6, 9, and 12 months.


Inclusion Criteria:

- Prior physician diagnosis of asthma

- current emergency visit for an acute asthma exacerbation, requiring nebulized
albuterol therapy

- Persistent or poor control of asthma, defined by NHLBI guidelines

Exclusion Criteria:

- Inability to speak and understand either English or Spanish

- No access to a phone for follow-up surveys

- Participation in another asthma study at the time of enrollment, or a sibling
participating in this or another study Other significant medical conditions that could
interfere with assessment of asthma-related measures

- children in foster care or other situations in which consent cannot be obtained from a
legal guardian
We found this trial at
1
site
60 Crittenden Blvd # 70
Rochester, New York 14642
(585) 275-2121
Phone: 585-275-8220
University of Rochester The University of Rochester is one of the country's top-tier research universities....
?
mi
from
Rochester, NY
Click here to add this to my saved trials